JACK RUBIN: Open Payments
NPI 1700882479 · LOS ALAMITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 45 payments from 16 companies in 2025. Trend: 2023 $568 · 2024 $790 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 8 | $191 |
| Otsuka America Pharmaceutical, Inc. | 7 | $171 |
| Ardelyx, Inc. | 4 | $84 |
| Calliditas Therapeutics US Inc. | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Novo Nordisk Inc | 3 | $67 |
| SCPHARMACEUTICALS INC. | 3 | $67 |
| Aurinia Pharma U.S., Inc. | 3 | $58 |
| Apellis Pharmaceuticals, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: Vafseo, JYNARQUE, IBSRELA, TARPEYO, Kerendia, Ozempic, FUROSCIX, LUPKYNIS.
Industry payments across CA — which companies pay providers there.
